Increased ceramide in brains with Alzheimer's and other neurodegenerative diseases

Filippov, Valery, Song, Minwoo Andrew, Zhang, Kangling, Vinters, Harry V., Tung, Spencer, Kirsch, Wolff M., Yang, Jun, Duerksen-Hughes, Penelope J.·2012·Journal of Alzheimer s Disease
DOI 10.3233/jad-2011-111202

Cited by (264)

Items 101–200 of 264

  1. Modulations of bioactive lipids and their receptors in postmortem Alzheimer’s disease brains
    Makoto Kurano, Yuko Saito, Baasanjav Uranbileg, Daisuke Saigusa, Kuniyuki Kano, Junken Aoki, Yutaka Yatomi · 2022 · Frontiers in Aging Neuroscience
  2. Ceramide/Sphingosine 1-Phosphate Axis as a Key Target for Diagnosis and Treatment in Alzheimer’s Disease and Other Neurodegenerative Diseases
    Antía Custodia, Daniel Romaus‐Sanjurjo, Marta Aramburu-Núñez, Diego Álvarez-Rafael, Laura Vázquez‐Vázquez, Javier Camino-Castiñeiras, Yago Leira, Juan Manuel Pías Peleteiro, José Manuel Aldrey, Tomás Sobrino et al. · 2022 · International Journal of Molecular Sciences
  3. Intestinal Microbiota Remodeling Protects Mice from Western Diet-Induced Brain Inflammation and Cognitive Decline
    Prasant Kumar Jena, Tahereh Setayesh, Lili Sheng, Jacopo Di Lucente, Lee Way Jin, Yu‐Jui Yvonne Wan · 2022 · Cells
  4. The impact of EPA and DHA on ceramide lipotoxicity in the metabolic syndrome
    Chelsey Walchuk, Yidi Wang, Miyoung Suh · 2020 · British Journal Of Nutrition
  5. Decoding ceramide function: how localization shapes cellular fate and how to study it
    Shweta Chitkara, Gunes Ekin Atilla‐Gokcumen · 2025 · Trends in Biochemical Sciences
  6. Towards Lipidomics of Low-Abundant Species for Exploring Tumor Heterogeneity Guided by High-Resolution Mass Spectrometry Imaging
    Jonathan Cimino, David Calligaris, Johann Far, Delphine Debois, Silvia Blacher, Nor Eddine Sounni, Agnès Noël, Edwin De Pauw · 2013 · International Journal of Molecular Sciences
  7. A Lipidomics Approach to Assess the Association Between Plasma Sphingolipids and Verbal Memory Performance in Coronary Artery Disease Patients Undertaking Cardiac Rehabilitation: A C18:0 Signature for Cognitive Response to Exercise
    Mahwesh Saleem, Nathan Herrmann, Adam Dinoff, Michelle M. Mielke, PAUL I. OH, Prathiba Shammi, Xingshan Cao, Swarajya Lakshmi Vattem Venkata, Norman J. Haughey, Krista L. Lanctôt · 2017 · Journal of Alzheimer s Disease
  8. What can lipidomics tell us about the pathogenesis of Alzheimer disease?
    Yanhui Xiang, Sin Man Lam, Guanghou Shui · 2015 · Biological Chemistry
  9. Partial Inhibition of Complex I Restores Mitochondrial Morphology and Mitochondria-ER Communication in Hippocampus of APP/PS1 Mice
    Jessica Panes-Fernández, Thi Kim Oanh Nguyen, Huanyao Gao, Trace A. Christensen, Andrea Stojakovic, Sergey Trushin, Jeffrey L. Salisbury, Jorge Fuentealba, Eugenia V. Trushina · 2023 · Cells
  10. Ceramides may Play a Central Role in the Pathogenesis of Alzheimer’s Disease: a Review of Evidence and Horizons for Discovery
    Hans O. Kalkman, Lukasz Smigielski · 2025 · Molecular Neurobiology
  11. Sphingolipids and impaired hypoxic stress responses in Huntington disease
    Johannes Burtscher, Giuseppe Pepe, Niran Maharjan, Nathan Riguet, Alba Di Pardo, Vittorio Maglione, Grégoire Paul Millet · 2023 · Progress in Lipid Research
  12. Mass Spectrometric Analysis of Urinary N-Glycosylation Changes in Patients with Parkinson’s Disease
    Mingming Xu, Hong Jin, Wei Ge, Lingbo Zhao, Zhaoliang Liu, Zeyu Guo, Zhen Wu, Jing Chen, Chengjie Mao, Xumin Zhang et al. · 2023 · ACS Chemical Neuroscience
  13. Plasma Ceramides and Neuropsychiatric Symptoms of Alzheimer’s Disease
    Yi Xing, Yi Tang, Lina Zhao, Qi Wang, Wei Qin, Jinlan Zhang, Jianping Jia · 2016 · Journal of Alzheimer s Disease
  14. Pathological manifestations of Farber disease in a new mouse model
    Nadine Beckmann, Stephanie Kadow, Fabian Schumacher, Joachim Rudolf Göthert, Stefanie Kesper, Annette Draeger, Walter Schulz‐Schaeffer, Jiang Wang, Jan Ulrich Becker, M. Krämer et al. · 2018 · Biological Chemistry
  15. Hyperphosphorylation of tau by GSK-3β in Alzheimer’s disease: The interaction of Aβ and sphingolipid mediators as a therapeutic target
    Maja Jazvinšćak Jembrek, Mirjana Babić Leko, Nela Pivac, Patrick R. Hof, Goran Šimić · 2013 · Translational Neuroscience
  16. Differences in plasma metabolites related to Alzheimer's disease, APOE ε4 status, and ethnicity
    Badri Narayan Vardarajan, Vrinda Kalia, Jennifer Jaie Manly, Adam M. Brickman, Dolly Reyes‐Dumeyer, Rafael Lantigua, Iuliana Ionita‐Laza, Dean P. Jones, Gary W. Miller, Richard P Mayeux · 2020 · Alzheimer s & Dementia Translational Research & Clinical Interventions
  17. Peripheral sphingolipids are associated with variation in white matter microstructure in older adults
    Christopher E. Gonzalez, Vijay K. Venkatraman, Yang An, Bennett A. Landman, Christos A. Davatzikos, Veera Venkata Ratnam Bandaru, Norman J. Haughey, Luigi Ferrucci, Michelle M. Mielke, Susan M. Resnick · 2016 · Neurobiology of Aging
  18. Vitamin B12 Attenuates Changes in Phospholipid Levels Related to Oxidative Stress in SH-SY5Y Cells
    Elena Leoni Theiss, Lea Victoria Griebsch, Anna Andrea Lauer, Daniel Janitschke, Vincent Konrad Johannes Erhardt, Elodie Christiane Haas, Konstantin Nicolas Kuppler, Juliane Radermacher, Oliver Walzer, Dorothea Portius et al. · 2022 · Cells
  19. Clinical Significance of Electronegative Low-Density Lipoprotein Cholesterol in Atherothrombosis
    Chih‐Sheng Chu, Shi Hui Law, David Lenzen, Yong-Hong Tan, Shih‐Feng Weng, Etsuro Ito, Jung‐Chou Wu, Chu‐Huang Chen, Hua‐Chen Chan, Liang‐Yin Ke · 2020 · Biomedicines
  20. Transmissible Endosomal Intoxication: A Balance between Exosomes and Lysosomes at the Basis of Intercellular Amyloid Propagation
    A. Bécot, C. Volgers, G. van Niel · 2020 · Biomedicines
  21. Chronic nSMase inhibition suppresses neuronal exosome spreading and sex-specifically attenuates amyloid pathology in APP knock-in Alzheimer's disease mice
    Francesca Elisabeth Mowry, Francisco Espejo‐Porras, Shijie Jin, Zainuddin Quadri, Limin Wu, Marcela Bertolio, Rachel Jarvis, Caroline R. Reynolds, Rashed Alananzeh, Erhard Bieberich et al. · 2023 · Neurobiology of Disease
  22. Lipid-enriched diet rescues lethality and slows down progression in a murine model of VCP-associated disease
    Katrina J. Llewellyn, Angèle Nalbandian, Kwang‐Mook Jung, Christopher Nguyen, Agnesa Avanesian, Tahseen Mozaffar, Daniele Piomelli, Virginia E. Kimonis · 2013 · Human Molecular Genetics
  23. Chronic Exposure of Adult Zebrafish to Polyethylene and Polyester-based Microplastics: Metabolomic and Gut Microbiome Alterations Reflecting Dysbiosis and Resilience
    Carl Angelo Medriano, Sungpyo Kim, Lan Hee Kim, Sungwoo Bae · 2024 · Journal of Hazardous Materials
  24. The Biology of Veganism: Plasma Metabolomics Analysis Reveals Distinct Profiles of Vegans and Non-Vegetarians in the Adventist Health Study-2 Cohort
    Fayth L. Miles, Michael J. Orlich, Andrew Mashchak, Paulette D. Chandler, Johanna W. Lampe, Penelope J. Duerksen-Hughes, Gary E. Fraser · 2022 · Nutrients
  25. Insulin treatment increases myocardial ceramide accumulation and disrupts cardiometabolic function
    Aimee E. Hodson, Trevor S. Tippetts, Benjamin T. Bikman · 2015 · Cardiovascular Diabetology
  26. Metabolic Profiling of Cognitive Aging in Midlife
    Zhiguang Huo, Brinda K. Rana, Jeremy A. Elman, Ruocheng Dong, Corinne D. Engelman, Sterling C. Johnson, Michael J. Lyons, Carol E. Franz, William S. Kremen, Jinying Zhao · 2020 · Frontiers in Aging Neuroscience
  27. Neutral Sphingomyelinase 2 Mediates Oxidative Stress Effects on Astrocyte Senescence and Synaptic Plasticity Transcripts
    Zhihui Zhu, Zainuddin Quadri, Simone M. Crivelli, Ahmed M. Elsherbini, Liping Zhang, Priyanka Tripathi, Haiyan Qin, Emily Roush, Stefka D. Spassieva, Mariana Nikolova‐Karakashian et al. · 2022 · Molecular Neurobiology
  28. Genetic variation modifies risk for neurodegeneration based on biomarker status
    Timothy J. Hohman, Mary Ellen I. Koran, Tricia A. Thornton‐Wells · 2014 · Frontiers in Aging Neuroscience
  29. Role of dietary and nutritional interventions in ceramide-associated diseases
    Shengnan Wang, Zihui Jin, Biyu Wu, Andrew J. Morris, Pan Deng · 2024 · Journal of Lipid Research
  30. Ceramide analog [18F]F-HPA-12 detects sphingolipid disbalance in the brain of Alzheimer’s disease transgenic mice by functioning as a metabolic probe
    Simone M. Crivelli, Daan van Kruining, Qian Luo, Jo Stevens, Caterina Giovagnoni, Andreas Paulus, Matthias Bauwens, Dušan Berkeš, Helga E. de Vries, Monique T Mulder et al. · 2020 · Scientific Reports
  31. Cannabidiol – A phytocannabinoid that widely affects sphingolipid metabolism under conditions of brain insulin resistance
    Tomasz Charytoniuk, Klaudia Sztolsztener, Ewa Harasim‐Symbor, Klaudia Berk, Adrian Chabowski, Karolina Konstantynowicz-Nowicka · 2021 · Biomedicine & Pharmacotherapy
  32. Plasma sphingomyelin and longitudinal change in percent emphysema on CT. The MESA Lung study
    Firas Salem Ahmed, Xian‐Cheng Jiang, Joseph E. Schwartz, Eric A. Hoffman, Joseph Yeboah, Steven Shea, Kristin M. Burkart, R. Graham Barr · 2014 · Biomarkers
  33. Association of Lipidomics Signatures in Blood with Clinical Progression in Preclinical and Prodromal Alzheimer’s Disease
    Fatemah Sakr, Alzheimer’s Disease Neuroimaging Initiative, Martin Dyrba, Anja Bräuer, Stefan Teipel · 2021 · Journal of Alzheimer s Disease
  34. Molecular profiling of the stroke-induced alterations in the cerebral microvasculature reveals promising therapeutic candidates
    Keri Callegari, Sabyasachi Dash, Hiroki Uchida, Yuto Shingai, Catherine Liu, Anne Khodarkovskaya, Yunkyoung Lee, Akira Ito, Amanda Lopez, Tuo Zhang et al. · 2023 · Proceedings of the National Academy of Sciences
  35. Ceramide Domains in Health and Disease: A Biophysical Perspective
    Ana E. Ventura, Beatriz Mestre, Liana C. Silva · 2019 · Advances in experimental medicine and biology
  36. APOE4 to APOE2 allelic switching in mice improves Alzheimer’s disease-related metabolic signatures, neuropathology and cognition
    Golden, Lesley R., Siano, Dahlia S., Stephens, Isaiah O., MacLean, Steven M., Saito, Kai, Nolt, Georgia L., Funnell, Jessica L., Pallerla, Akhil V., Lee, Sangderk, Smith, Cathryn et al. · 2025 · Nature Neuroscience
  37. Diets with Higher ω-6/ω-3 Ratios Show Differences in Ceramides and Fatty Acid Levels Accompanied by Increased Amyloid-Beta in the Brains of Male APP/PS1 Transgenic Mice
    Lara Ordóñez‐Gutiérrez, Gemma Fabriàs, Josefina Casas, Francisco G. Wandosell · 2021 · International Journal of Molecular Sciences
  38. Increased isoprostanoid levels in brain from murine model of Krabbe disease – Relevance of isoprostanes, dihomo-isoprostanes and neuroprostanes to disease severity
    Cinzia Signorini, Venera Cardile, Giovanna Pannuzzo, Adriana Carol Eleonora Graziano, Thierry Durand, Jean‐Marie Galano, Camille Oger, Silvia Leoncini, Alessio Cortelazzo, Jetty Chung‐Yung Lee et al. · 2019 · Free Radical Biology and Medicine
  39. Lipid domain formation and membrane shaping by C24-ceramide
    Ana E. Ventura, Ana R.P. Varela, Tamir Dingjan, Tânia C.B. Santos, Alexander Fedorov, Anthony H. Futerman, Manuel J. E. PRIETO, Liana C. Silva · 2020 · Biochimica et Biophysica Acta (BBA) - Biomembranes
  40. Synthesis, Radiosynthesis, and Preliminary in vitro and in vivo Evaluation of the Fluorinated Ceramide Trafficking Inhibitor (HPA-12) for Brain Applications
    Simone M. Crivelli, Andreas Paulus, Jozef Markus, Matthias Bauwens, Dušan Berkeš, Helga E. de Vries, Monique T Mulder, Jochen Walter, Felix Manuel Mottaghy, Mario H. Losen et al. · 2017 · Journal of Alzheimer s Disease
  41. Association of Lipidomics Signatures in Blood with Clinical Progression in Preclinical and Prodromal Alzheimer's Disease.
    Fatemah A. Sakr, Martin Dyrba, Anja Ursula Bräuer, Stefan Johannes Teipel, Alzheimer’s Disease Neuroimaging Initiative · 2022 · DZNE Pub
  42. System level modeling and analysis of TNF-α mediated sphingolipid signaling pathway in neurological disorders for the prediction of therapeutic targets
    Sanam Banaras, Rehan Zafar Paracha, Maryum Nisar, Ayesha Arif, Jamil Ahmad, Muhammad Tariq Saeed, Zartasha Mustansar, Malik Nawaz Shuja, Rizwan Nasir Paracha · 2022 · Frontiers in Physiology
  43. A Targeted Mass Spectrometry Approach to Identify Peripheral Changes in Metabolic Pathways of Patients with Alzheimer’s Disease
    Pierluigi Reveglia, Carmela Paolillo, Antonella Angiolillo, Gabriella Ferretti, Ruggero Angelico, Rossana Sirabella, Gaetano Corso, Carmela Matrone, Alfonso Di Costanzo · 2023 · International Journal of Molecular Sciences
  44. Mapping the lipidome in mitochondria‐associated membranes ( MAMs ) in an in vitro model of Alzheimer's disease
    Tânia Fernandes, Tânia Melo, Tiago Conde, Bruna Neves, Pedro M. Domingues, Rosa Resende, Cláudia Pereira, Paula Isabel Moreira, M. Rosário Domingues · 2024 · Journal of Neurochemistry
  45. Links between Insulin Resistance, Lipoprotein Metabolism and Amyloidosis in Alzheimer’s Disease
    Ian James Martins, Rhona Creegan · 2014 · Health
  46. Ceramide Accumulation Is Associated with Declining Verbal Memory in Coronary Artery Disease Patients: An Observational Study
    Parco Chan, Mahwesh Saleem, Nathan Herrmann, Michelle M. Mielke, Norman J. Haughey, PAUL I. OH, Alexander Kiss, Krista L. Lanctôt · 2018 · Journal of Alzheimer s Disease
  47. A bidirectional link between sulfatide and Alzheimer’s disease
    Valerie C. Zimmer, Anna Andrea Lauer, Viola J. Haupenthal, Christoph P. Stahlmann, Janine Mett, Sven Grösgen, Benjamin Hundsdörfer, Tatjana L. Rothhaar, Kristina Endres, Matthias Eckhardt et al. · 2023 · Cell chemical biology
  48. Original article Sphingosine kinases modulate the secretion of amyloid β precursor protein from SH-SY5Y neuroblastoma cells: the role of α-synuclein
    Henryk M. Jęśko, Taro Okada, Robert Piotr Strosznajder, Shun‐ichi Nakamura · 2014 · Folia Neuropathologica
  49. Administration of an Acidic Sphingomyelinase (ASMase) Inhibitor, Imipramine, Reduces Hypoglycemia-Induced Hippocampal Neuronal Death
    A Ra Kho, Bo Young Choi, Song Hee Lee, Dae Ki Hong, Beom Seok Kang, Si Hyun Lee, Sang Won Suh · 2022 · Cells
  50. Sphingosine-1-Phosphate and Its Effect on Glucose Deprivation/Glucose Reload Stress: From Gene Expression to Neuronal Survival
    Kinga Czubowicz, Magdalena Cieślik, Joanna Pyszko, Joanna Benigna Strosznajder, Robert Piotr Strosznajder · 2014 · Molecular Neurobiology
  51. Network Analysis of a Comprehensive Knowledge Repository Reveals a Dual Role for Ceramide in Alzheimer’s Disease
    Satoshi Mizuno, Soichi Ogishima, Kazuyuki Kitatani, Masataka Kikuchi, Hiroshi Tanaka, Nobuo Yaegashi, Jun Nakaya · 2016 · PLoS ONE
  52. Temporal Effects of Neuron-specific beta-secretase 1 (BACE1) Knock-in on the Mouse Brain Metabolome: Implications for Alzheimer's Disease
    Xiaobei Pan, Brian D. Green · 2018 · Neuroscience
  53. The physiological and pathological effects of sphingolipid metabolism and signaling in the central nervous system
    Tian Li, Haoying He, Ejuan Zhang, Fengjiao Hu, Zhuo Wang, Jian Xu, Mengliu Zeng, Biwen Peng · 2025 · Brain Pathology
  54. Mass Spectrometric Imaging of Anionic Phospholipids Desorbed from Human Hippocampal Sections: Discrimination between Temporal and Nontemporal Lobe Epilepsies
    Supratim Mondal, Abhijit Nandy, Geetha Dande, Krishna Prabhu, Rajesh Ramanna Valmiki, Debasish Koner, Shibdas Banerjee · 2024 · ACS Chemical Neuroscience
  55. Metabolic profiling reveals dysregulated lipid metabolism and potential biomarkers associated with the development and progression of Fragile X‐Associated Tremor/Ataxia Syndrome (FXTAS)
    Marwa Zafarullah, Grzegorz Palczewski, Susan Michelle Rivera, David R. Hessl, Flora Tassone · 2020 · The FASEB Journal
  56. The relationship among amyloid-β deposition, sphingomyelin level, and the expression and function of P-glycoprotein in Alzheimer’s disease pathological process
    Qing Yang, Zikang Xing, Lisha Du, Xin Fang, Heng Liang, Shengnan Zhang, Lei Shi, Chunxiang Kuang, Tian-Xiong Han · 2022 · Neural Regeneration Research
  57. Alterations in endo-lysosomal function induce similar hepatic lipid profiles in rodent models of drug-induced phospholipidosis and Sandhoff disease
    Emmanuelle Lecommandeur, David Baker, Timothy Martin Cox, Andrew W. Nicholls, Julian Leether Griffin · 2017 · Journal of Lipid Research
  58. Sphingolipids and Inositol Phosphates Regulate the Tau Protein Phosphorylation Status in Humanized Yeast
    Francisca Rández‐Gil, Lino Bojunga, Francisco Estruch, Joris Winderickx, Maurizio Del Poeta, Jose Antonio Prieto · 2020 · Frontiers in Cell and Developmental Biology
  59. Ceramide contributes to pathogenesis and may be targeted for therapy in VCP inclusion body myopathy
    Lan Nguyen Weiss, Kwang‐Mook Jung, Angèle Nalbandian, Katrina J. Llewellyn, Howard Yu, Lac Ta, Isabela Wen-Chi Chang, Marco Migliore, Erica Squire, Faizy Ahmed et al. · 2020 · Human Molecular Genetics
  60. Exploring the significance of lipids in Alzheimer's disease and the potential of extracellular vesicles
    Huaqi Su, Colin Louis Masters, Ashley Ian Bush, Kevin Jeffrey Barnham, Gavin E. Reid, Laura J. Vella · 2023 · PROTEOMICS
  61. Towards a Unitary Hypothesis of Alzheimer’s Disease Pathogenesis
    E. Area-Gómez, E. Schon · 2024 · Journal of Alzheimer's Disease
  62. Aggregation Behavior of Amyloid Beta Peptide Depends Upon the Membrane Lipid Composition
    Lipika Mirdha · 2024 · The Journal of Membrane Biology
  63. The influence of metabolic disorders on adaptive immunity
    Thomas J. C. Collins, Pooranee K. Morgan, Kevin Man, Graeme Iain Lancaster, Andrew James Murphy · 2024 · Cellular and Molecular Immunology
  64. Multi Layered Omics Approaches Reveal Glia Specific Alterations in Alzheimer's Disease: A Systematic Review and Future Prospects
    Özkan İş, Yuhao Min, Xue Wang, Stephanie R. Oatman, Ann Abraham Daniel, Nilüfer Ertekin‐Taner · 2024 · Glia
  65. Human Brain Lipidomics: Utilities of Chloride Adducts in Flow Injection Analysis
    Paul L. Wood, Kathleen A. Hauther, Jon H. Scarborough, Dustin J. Craney, Beatrix Dudzik, John E. Cebak, Randall L. Woltjer · 2021 · Life
  66. Plasma Sphingomyelins in Late-Onset Alzheimer’s Disease
    Gianna Fote, Jie Wu, Mark E. Mapstone, Fabio M. Macciardi, Massimo S. Fiandaca, Howard J. Federoff · 2021 · Journal of Alzheimer s Disease
  67. A new model for fatty acid hydroxylase-associated neurodegeneration reveals mitochondrial and autophagy abnormalities
    Frida Mandik, Yuliia Kanana, Jost Rody, Sophie Misera, Bernd Wilken, Björn‐Hergen Laabs, Christine Klein, Melissa Harju Vos · 2022 · Frontiers in Cell and Developmental Biology
  68. Role of de novo lipogenesis in inflammation and insulin resistance in Alzheimer's disease
    Mohsin Ali Khan, Zaw Ali Khan, Fouzia Shoeb, Ghizal Fatima, Rizwan Hasan Khan, Mohammad M. Khan · 2023 · International Journal of Biological Macromolecules
  69. Cerebral Gray and White Matter Monogalactosyl Diglyceride Levels Rise with the Progression of Alzheimer’s Disease
    Jan Krzysztof Blusztajn, Nurgül Aytan, Thekkelnaycke M. Rajendiran, Tiffany J. Mellott, Tanu Soni, Charles Burant, Geidy E. Serrano, Thomas G. Beach, Honghuang Lin, Thor D. Stein · 2023 · Journal of Alzheimer s Disease
  70. Integrated multi-omics approaches reveal the neurotoxicity of triclocarban in mouse brain
    Qian Song, Chengchen Hu, Xueying Zhang, Pengweilin Ji, Yansong Li, Hanyong Peng, Yuxin Zheng, Hongna Zhang · 2024 · Environment International
  71. Comparative atomic-scale hydration of the ceramide and phosphocholine headgroup in solution and bilayer environments
    Richard J. Gillams, Christian D. Lorenz, Sylvia E. McLain · 2016 · The Journal of Chemical Physics
  72. Pathology and Treatments of Alzheimer’s Disease Based on Considering Changes in Brain Energy Metabolism Due to Type 2 Diabetes
    Hidekatsu Yanai, Hiroki Adachi, Mariko Hakoshima, Hisayuki Katsuyama · 2024 · Molecules
  73. Neutral sphingomyelinase 2: A promising drug target for CNS disease
    Meixiang Huang, Matthew H. Stremlau, Jason Zavras, Cristina Zivko, Ajit G. Thomas, Peter Pietri, Vasiliki Machairaki, Barbara Stauch Slusher · 2024 · Advances in pharmacology
  74. Sphingolipidomics analysis of large clinical cohorts. Part 2: Potential impact and applications
    Joyce Ruifen Chong, Ping Xiang, Wei Wang, Tatsuma Hind, Wee Siong Chew, Wei‐Yi Ong, Mitchell K.P. Lai, Deron Raymond Herr · 2018 · Biochemical and Biophysical Research Communications
  75. The Current Landscape in the Development of Small-molecule Modulators Targeting Sphingosine-1-phosphate Receptors to Treat Neurodegenerative Diseases
    Sidhartha Sankar Kar, Soumya Ranjan Gharai, Sujit Kumar Sahu, V. Ravichandiran, Sharada Prasanna Swain · 2024 · Current Topics in Medicinal Chemistry
  76. Sphingosine 1-phosphate receptor subtype 1 (S1P1) activity in the course of Alzheimer's disease
    Jonatan Martínez‐Gardeazabal, Gorka Pereira‐Castelo, Marta Moreno‐Rodríguez, Alberto Llorente‐Ovejero, Manuel Fernández, Ivan Fernández‐Vega, Iván Manuel, Rafael Rodríguez‐Puertas · 2024 · Neurobiology of Disease
  77. Untargeted Lipidomic Reveals Potential Biomarkers in Plasma Samples for the Discrimination of Patients Affected by Parkinson’s Disease
    Kateryna Tkachenko, J.M. González-Sáiz, Consuelo Pizarro · 2025 · Molecules
  78. Differential regulation of sphingolipid metabolism in plasma, hippocampus, and cerebral cortex of mice administered sphingolipid modulating agents
    Corey Giles, Ryusuke Takechi, Natalie A. Mellett, Peter J. Meikle, Satvinder Singh Dhaliwal, John C.L. Mamo · 2017 · Journal of Neurochemistry
  79. Cerebrospinal fluid proteomics in recent-onset Narcolepsy type 1 reveals activation of the complement system
    Ikram Ayoub, Yves A Dauvilliers, Lucie Barateau, Thaïs Vermeulen, Emmanuelle Mouton‐Barbosa, Marlène Marcellin, Anne Gonzalez de Peredo, Catharina C. Groß, Abdelhadi Saoudi, Roland Liblau · 2023 · Frontiers in Immunology
  80. Treadmill intervention attenuates motor deficit with 6-OHDA-induced Parkinson’s disease rat via changes in lipid profiles in brain and muscle
    Binar Panunggal, Tu‐Hsueh Yeh, Shu‐Ping Tsao, Chun Pan, Wei-Ting Shih, Ya‐Tin Lin, Amelia Faradina, Chia‐Lang Fang, Hui-Yu Huang, Shih‐Yi Huang · 2025 · Aging
  81. Investigating the neuroprotective effects of Dracocephalum moldavica extract and its effect on metabolomic profile of rat model of sporadic Alzheimer's disease
    Marjan Talebi, Seyed Abdulmajid Ayatollahi, Mohammad Ali As’habi, Farzad Kobarfard, Mona Khoramjouy, Farzaneh Niki Boroujeni, Mehrdad Faizi, Alireza Ghassempour · 2025 · Heliyon
  82. Pleiotropic Effect of Human ApoE4 on Cerebral Ceramide and Saturated Fatty Acid Levels
    Sandra den Hoedt, Carola I.F. Janssen, Giuseppe Astarita, Daniele Piomelli, Frank P. J. Leijten, Simone M. Crivelli, Adrie J.M. Verhoeven, Helga E. de Vries, Jochen Walter, Pilar Martínez‐Martínez et al. · 2016 · Journal of Alzheimer s Disease
  83. Protective mechanisms against Alzheimer's disease in APOE3‐Christchurch homozygous astrocytes
    Tian, Xinran, Rivera, Erica Keane, Hwang, Inyoung, Nikitina, Arina A., Smith, Jennifer A., Cho, Youngsuh J., Sala‐Jarque, Julia, DuBose, Austin, Andriola, Clare, Gollan‐Myers, Toby et al. · 2025 · Alzheimer's & Dementia
  84. Role of saturated fatty acid metabolism in posttranslational modifications of the Tau protein
    Valeria Melissa García-Cruz, Roberto Coria, Clorinda Arias · 2025 · Molecular and Cellular Biochemistry
  85. Lysosomal homeostasis at the crossroads of neurodegeneration
    Stefano De Tito, Sharon A. Tooze · 2026 · Journal of Clinical Investigation
  86. Lipidomic changes of cerebral cortex in aldehyde dehydrogenase-2 knock-in heterozygote mice after chronic alcohol exposure
    Xiao Li, Jin Xiang, Xinyu Liu, Lin Yang, Ying Wei, Shiyong Fang, Jing Li, Yi Ye · 2023 · Frontiers in Molecular Neuroscience
  87. Lipidomics and proteomics: An integrative approach for early diagnosis of dementia and Alzheimer’s disease
    Virendra Tiwari, Shubha Shukla · 2023 · Frontiers in Genetics
  88. Astrocytic functions and lipid metabolism: Correlations and therapeutic targets in Alzheimer's disease and glioblastoma
    Xu Zhang, Rongrong Gao, Liuke Yang, Youwei Zhu, Tiancheng Zhang, Xiaorong Shen, Wenwen Gu, Long Yang, Shenjie Peng · 2024 · Clinical and Translational Discovery
  89. New Insights on Non-Enzymatic Oxidation of Ganglioside GM1 Using Mass Spectrometry
    Daniela Couto, Tânia Melo, Elisabete A. Maciel, Ana Margarida Ferreira Campos, Eliana Alves, Sofia de Morais Guedes, M. Rosário Domingues, Pedro M. Domingues · 2016 · Journal of the American Society for Mass Spectrometry
  90. Small molecule biomarkers in Alzheimer’s disease
    Min Gyu Kim, Cristina Legido‐Quigley · 2018 · OCL
  91. The role of ceramide and SEW 2871 in the transcription of enzymes involved in amyloid b precursor protein metabolism in an experimental model of Alzheimer’s disease
    Kinga Czubowicz, Sylwia Wójtowicz, Przemysław Leonard Wencel, Robert Piotr Strosznajder · 2018 · Folia Neuropathologica
  92. Sex-Biased Expression and Response of microRNAs in Neurological Diseases and Neurotrauma
    Urim Geleta, Paresh Prajapati, Adam D. Bachstetter, Peter T. Nelson, Wang‐Xia Wang · 2024 · International Journal of Molecular Sciences
  93. Ceramides Mediate Insulin-Induced Impairments in Cerebral Mitochondrial Bioenergetics in ApoE4 Mice
    Sheryl T. Carr, Erin R. Saito, Chase M. Walton, Jeremy Y. Saito, Cameron M. Hanegan, Cali E. Warren, Annie M. Trumbull, Benjamin T. Bikman · 2023 · International Journal of Molecular Sciences
  94. A Neurotoxic Glycerophosphocholine Impacts PtdIns-4, 5-Bisphosphate and TORC2 Signaling by Altering Ceramide Biosynthesis in Yeast
    Michael A. Kennedy, Kenneth S. Gable, Karolina Niewola‐Staszkowska, Susana Abreu, Anne Johnston, Linda J. Harris, Fulvio Reggiori, Robbie Loewith, Teresa M. Dunn, Steffany A. L. Bennett et al. · 2014 · PLoS Genetics
  95. Abnormal Lipid Metabolism and Altered Neuronal Support by Astrocytes Lacking Akap11 , a Risk Gene for Schizophrenia and Bipolar Disorder
    Xiao‐Man Liu, Horia Pribiag, Deeksha Misri, Kwanho Kim, Kira A. Perzel Mandell, Bryan J. Song, David R. Graykowski, Olivia Seidel, Nolan D. Hartley, Mateo Herrera et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  96. Guardians of homeostasis: Natural products target metabolic reprogramming in Alzheimer’s disease
    Zhenkai Zhang, Haonan Xu, Fuxia Zhao, Zheyue Han, Juan Pan, Mengmeng Li, Wei Guan, Peng Jiang, Zhichao Hao, Yiqiang Zhang et al. · 2025 · Ageing Research Reviews
  97. Serum lipidome associates with neuroimaging features in patients with traumatic brain injury
    Ilias Thomas, Virginia Newcombe, Alex M. Dickens, Sophie Richter, Jussi P. Posti, Andrew I.R. Maas, Olli S. Tenovuo, Tuulia Hyötyläinen, András Büki, David Krishna Menon et al. · 2024 · iScience
  98. Alterations in urinary ceramides, sphingoid bases, and their phosphates among patients with kidney disease
    Yoshifumi Morita, Eri Sakai, Hideaki Isago, Yoshikazu Ono, Yutaka Yatomi, Makoto Kurano · 2024 · Frontiers in Nephrology
  99. Transcriptomics analysis reveals potential regulatory role of nSMase2 (Smpd3) in nervous system development and function of middle‐aged mouse brains
    Zhihui Zhu, Timothy S. McClintock, Erhard Bieberich · 2024 · Genes Brain & Behavior
  100. Altered lipid metabolic homeostasis in the pathogenesis of Alzheimer’s disease
    Oana C. Marian, Collin L. Tran, A. Don · 2020 · Elsevier eBooks